日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack

病例报告：突变造血干细胞逃避T细胞攻击介导的重型再生障碍性贫血自发缓解

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1635943
Shiroshita, Kohei; Zaimoku, Yoshitaka; Kudo, Himari; Obara, Naoshi; Hosomichi, Kazuyoshi; Kano, Yui; Kobayashi, Miku; Morishita, Eriko; Takamatsu, Hiroyuki; Toyama, Takaaki; Nakao, Shinji
发育与干细胞
T细胞
代谢
T细胞
干细胞
细胞生物学
贫血
免疫/内分泌
发表日期：2025
文献求助 收藏

Real-World Data on the p.Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas

p.Gly17Val RHOA突变在诊断T滤泡辅助细胞淋巴瘤中的真实世界数据

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70955
Tsuboi, Yuri; Hattori, Keiichiro; Kurita, Naoki; Suehara, Yasuhito; Nanmoku, Toru; Matsuoka, Ryota; Ishii, Ryota; Suma, Sakurako; Makishima, Kenichi; Maruyama, Yumiko; Sakamoto, Tatsuhiro; Kato, Takayasu; Nishikii, Hidekazu; Obara, Naoshi; Matsubara, Daisuke; Sakata-Yanagimoto, Mamiko
RHOA
细胞生物学
淋巴瘤
发表日期：2025
文献求助 收藏

Treatment burden in patients with paroxysmal nocturnal hemoglobinuria: an in-depth interview survey

阵发性睡眠性血红蛋白尿患者的治疗负担：一项深入访谈调查

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06486-9
Ueda, Yasutaka; Obara, Naoshi; Ueno, Shikiko; Sakurai, Masatoshi; Hosokawa, Kohei; Murata, Tatsunori; Fukuoka, Yuta; Hayama, Nozomi; Yamashita, Masami; Ogawa, Yoshiaki; Usuki, Kensuke; Ikezoe, Takayuki; Kawaguchi, Tatsuya; Hosen, Naoki; Kanakura, Yuzuru; Gotoh, Akihiko; Nishimura, Jun-Ichi
发表日期：2025
文献求助 收藏

Safety of Post-transplant Cyclophosphamide as a Single Agent for Graft-Versus-Host Disease Prophylaxis After Human Leukocyte Antigen (HLA)-Matched Transplantation With the Japanese Population: A Single-Center Phase Ⅰ/Ⅱ Study

在日本人群中，单药环磷酰胺用于人类白细胞抗原（HLA）匹配移植后移植物抗宿主病预防的安全性：一项单中心Ⅰ/Ⅱ期研究

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.100251
Joyce, Miki; Kurita, Naoki; Mathis, Bryan J; Makishima, Kenichi; Suma, Sakurako; Sasaki, Yuya; Suehara, Yasuhito; Hattori, Keiichiro; Sakamoto, Tatsuhiro; Kato, Takayasu; Obara, Naoshi; Chiba, Shigeru; Nishikii, Hidekazu; Sakata-Yanagimoto, Mamiko
细胞生物学
Human
发表日期：2025
文献求助 收藏

Multiple Myeloma in a Patient with Birt-Hogg-Dubé Syndrome

患有伯特-霍格-杜贝综合征的患者罹患多发性骨髓瘤

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.4985-24
Matsumura, Fumiaki; Sakamoto, Tatsuhiro; Kai, Hirayasu; Usui, Toshiaki; Kawanishi, Kunio; Matsuoka, Ryota; Ishitsuka, Kantaro; Makishima, Kenichi; Suma, Sakurako; Maruyama, Yumiko; Kato, Takayasu; Kurita, Naoki; Hattori, Keiichiro; Suehara, Yasuhito; Nishikii, Hidekazu; Obara, Naoshi; Usui, Joichi; Matsubara, Daisuke; Yamagata, Kunihiro; Sakata-Yanagimoto, Mamiko
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.

超越抗体回收利用：Crovalimab 的分子设计使其能够每四周进行一次皮下注射，用于治疗 PNH

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms252111679
Sampei Zenjiro, Haraya Kenta, Gan Siok Wan, Muraoka Masaru, Hayasaka Akira, Fukuzawa Taku, Shida-Kawazoe Meiri, Tsuboi Yoshinori, Gotoh Akihiko, Obara Naoshi, Ueda Yasutaka
免疫/内分泌
发表日期：2024
文献求助 收藏

Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine

女性和血小板计数正常的骨髓增生异常综合征患者亚组可从标准剂量阿扎胞苷治疗中获益。

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1938
Ogawa, Shinichi; Sakamoto, Tatsuhiro; Matsuoka, Ryota; Ishitsuka, Kantaro; Ogino, Yasuko; Sootome, Ayano; Makishima, Kenichi; Yoshida, Chikashi; Ito, Yufu; Shimizu, Seiichi; Suyama, Takuya; Shinagawa, Atsushi; Ito, Takayoshi; Obara, Naoshi; Kusakabe, Manabu; Sakata-Yanagimoto, Mamiko; Miyazaki, Yasushi; Nannya, Yasuhito; Chiba, Shigeru
血小板
发表日期：2024
文献求助 收藏

Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors

接受 C5 抑制剂治疗的阵发性睡眠性血红蛋白尿症日本患者的疾病负担

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-023-03698-5
Obara, Naoshi; Usuki, Kensuke; Hayashi, Takeshi; Fujii, Masato; Ikezoe, Takayuki
发表日期：2024
文献求助 收藏

A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom's macroglobulinemia

一项针对日本华氏巨球蛋白血症患者的伊布替尼联合利妥昔单抗的 II 期开放标签研究

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-024-03761-9
Izutsu, Koji; Kato, Hisashi; Sekiguchi, Naohiro; Fujisaki, Tomoaki; Kawakita, Toshiro; Obara, Naoshi; Matsue, Kosei; Nishimoto, Mitsutaka; Hatayama, Tomoyoshi; Inagaki, Mitsuo; Fujikawa, Ei
发表日期：2024
文献求助 收藏

Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings

罗米司亭治疗慢性特发性血小板减少性紫癜在真实世界中的长期安全性和有效性

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-024-03847-4
Obara, Naoshi; Hatanaka, Shigeki; Tsuji, Yukie; Higashi, Koji
血小板
发表日期：2024
文献求助 收藏